Teva settles dispute with AstraZeneca over diabetes drug

24-06-2016

Teva settles dispute with AstraZeneca over diabetes drug

Photo: Courtesy of Teva

Teva has settled its patent litigation dispute with AstraZeneca centring on diabetes drug Byetta (exenatide).


Teva, AstraZeneca, Byetta, patent, license

LSIPR